The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis
Open accessAbstract
Protein phosphatases have very recently emerged as important targets for chemical biology and medicinal chemistry research, and new phosphatase inhibitor classes are in high demand. The underlying frameworks of natural products represent the evolutionarily selected fractions of chemical space explored by nature so far and meet the criteria of relevance to nature and biological prevalidation most crucial to inhibitor development. We refer to synthesis efforts and compound collection development based on these criteria as biology-oriented synthesis. For the discovery of phosphatase inhibitor classes by means of this approach, four natural product-derived or -inspired medium-sized compound collections were synthesized and investigated for inhibition of the tyrosine phosphatases VE-PTP, Shp-2, PTP1B, MptpA, and MptpB and the dual-specificity phosphatases Cdc25A and VHR. The screen yielded four unprecedented and selective phosphatase inhibitor classes for four phosphatases with high hit rates. For VE-PTP and MptpB the first inhibitors were discovered. These results demonstrate that biology-oriented synthesis is an efficient approach to the discovery of new compound classes for medicinal chemistry and chemical biology research that opens up new opportunities for the study of phosphatases, which may lead to the development of new drug candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586
Protein Tyrosine Phosphatases in the Human Genome
Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., & Mustelin, T. (2004) · Cell · doi:10.1016/j.cell.2004.05.018 · Cited by 1,886
A Planning Strategy for Diversity‐Oriented Synthesis
Burke, M. D., & Schreiber, S. L. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200300626 · Cited by 1,493
Protein tyrosine phosphatase 1B inhibitors for diabetes
Johnson, T. O., Ermolieff, J., & Jirousek, M. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd895 · Cited by 653
Koch, M. A., Schuffenhauer, A., Scheck, M., Wetzel, S., Casaulta, M., Odermatt, A., Ertl, P., & Waldmann, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503647102 · Cited by 544
Self-citationCDC25 Phosphatases as Potential Human Oncogenes
Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., & Beach, D. (1995) · Science · doi:10.1126/science.7667636 · Cited by 504
Breinbauer, R., Vetter, I. R., & Waldmann, H. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020816)41:16<2878::aid-anie2878>3.0.co;2-b · Cited by 475
Self-citationInhibitors of Protein Tyrosine Phosphatases: Next‐Generation Drugs?
Bialy, L., & Waldmann, H. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461517 · Cited by 420
Self-citationInterplay between mycobacteria and host signalling pathways
Koul, A., Herget, T., Klebl, B., & Ullrich, A. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro840 · Cited by 365
Nawroth, R. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf497 · Cited by 313
From protein domains to drug candidates – natural products as guiding principles in
Breinbauer, R., Vetter, I., & Waldmann, H. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020816)41:16<2878::aid-anie2878>3.0.co;2 · Cited by 231
Self-citationKoch, M. A., Wittenberg, L.-O., Basu, S., Jeyaraj, D. A., Gourzoulidou, E., Reinecke, K., Odermatt, A., & Waldmann, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404719101 · Cited by 196
Self-citationPathak, M. K., & Yi, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3391 · Cited by 190
Fachinger, G., Deutsch, U., & Risau, W. (1999) · Oncogene · doi:10.1038/sj.onc.1202992 · Cited by 180
Koch, M. A., & Waldmann, H. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03419-7 · Cited by 168
Self-citationDual-specificity phosphatases as targets for antineoplastic agents
Lyon, M. A., Ducruet, A. P., Wipf, P., & Lazo, J. S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd963 · Cited by 160
Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain
Anderson, D. J., & Arnerić, S. P. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90200-3 · Cited by 159
Bäumer, S., Keller, L., Holtmann, A., Funke, R., August, B., Gamp, A., Wolburg, H., Wolburg-Buchholz, K., Deutsch, U., & Vestweber, D. (2006) · Blood · doi:10.1182/blood-2006-01-0141 · Cited by 158
Self-citationAlonso, A., Saxena, M., Williams, S., & Mustelin, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006497200 · Cited by 151
Kikuchi, H., Saito, Y., Komiya, J., Takaya, Y., Honma, S., Nakahata, N., Itô, A., & Oshima, Y. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo015657x · Cited by 73
Rosenbaum, C., Baumhof, P., Mazitschek, R., Müller, O., Giannis, A., & Waldmann, H. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200352582 · Cited by 58
Self-citation
Cited by
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
Thirumurugan, P., Matosiuk, D., & Jozwiak, K. (2013) · Chemical Reviews · doi:10.1021/cr200409f · Cited by 1,896
Natural products in drug discovery
Harvey, A. L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.004 · Cited by 1,832
Multicomponent Reaction Design in the Quest for Molecular Complexity and Diversity
Ruijter, E., Scheffelaar, R., & Orru, R. V. A. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006515 · Cited by 1,329
Galloway, W. R. J. D., Isidro-Llobet, A., & Spring, D. R. (2010) · Nature Communications · doi:10.1038/ncomms1081 · Cited by 891
Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
Newman, D. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0704090 · Cited by 716
Metadata
- Authors
- Nören-Müller, A., Reis-Corrêa, I., Prinz, H., Rosenbaum, C., Saxena, K., Schwalbe, H. J., Vestweber, D., Cagna, G., Schunk, S., Schwarz, O., Schiewe, H., & Waldmann, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-07-11
- Volume
- 103
- Issue
- 28
- Pages
- 10606-10611
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2142663968
- Cited by
- 303
- References
- 21
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.